查看購物車
  • English
  • Japanese
歐洲基因改造動物模型市場：按技術、動物類型、應用、最終用戶和國家分類的分析和預測（2025-2035 年）
市場調查報告書
商品編碼
2029915

歐洲基因改造動物模型市場：按技術、動物類型、應用、最終用戶和國家分類的分析和預測（2025-2035 年）

Europe Transgenic Animal Model Market: Focus on Technology, Animal Type, Application, End User, and Country - Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 80 Pages | 商品交期: 1-5個工作天內

價格

歐洲基因改造動物模型市場正經歷穩定成長，其驅動力包括對先進臨床前研究工具的需求不斷成長、生物技術投資不斷擴大以及在藥物發現和基因研究領域的應用日益廣泛。

基因改造動物模型在闡明疾病機制和開發標靶治療方面發揮著至關重要的作用。預計2025年至2035年預測期內，全球基因改造動物模型市場將顯著成長，其中歐洲憑藉其強大的研究基礎設施和監管支持，將成為主要的區域市場。德國、英國和法國等國家處於領先地位，引領基因工程和生物醫學研究領域的創新。預計到2035年，歐洲基因改造動物模型市場規模將從2025年的9.065億美元成長至22.347億美元，2025年至2035年預測期間的複合年成長率（CAGR）為9.44%。

關鍵市場統計數據
預測期 2025-2035
2025 年評估 9.065億美元
2035年預測 22.347億美元
複合年成長率 9.44%

歐洲基因改造動物模型市場是生命科學和生物技術產業的關鍵領域，專注於將外源基因導入其基因組的基因改造動物。這些模型廣泛應用於生物醫學研究，用於研究基因功能、疾病進展和治療反應。基因改造動物模型，尤其是小鼠和大鼠，已成為臨床前研究中不可或缺的工具，使科學家能夠精確地模擬人類疾病狀況。

在歐洲，基因組學、腫瘤學、神經病學和罕見疾病領域的研究活動活性化，推動了對基因改造動物模型的需求。在政府資助以及與製藥和生物技術公司合作的支持下，該地區強大的學術和研究生態系統正在加速採用先進的基因工程技術，例如 CRISPR/Cas9 和基因編輯平台。

此外，對個人化醫療和標靶治療的日益重視進一步推動了對精準可靠動物模型的需求。歐洲的法律規範確保了動物模型的倫理使用和標準化，從而促進了高品質的研究實踐。同時，領先的研究機構和生技公司的進駐也加速了基因改造動物模型的創新和商業化。

在對高效藥物發現和疾病建模的需求不斷成長，以及技術進步和研發投入增加的支持下，歐洲基因改造動物模型市場預計將大幅擴張。

市場區隔:

細分 1：按技術

  • CRISPR/Cas-9
  • 顯微注射
  • 胚胎幹細胞注射
  • 其他

第二部分：依動物類型

  • 囓齒動物（小鼠和大鼠）
  • 兔子
  • 豬
  • 其他

細分3：按應用

  • 藥物發現和藥物開發
  • 疾病研究
  • 基因功能研究
  • 毒性評估和安全性測試
  • 其他

細分 4：按最終用戶

  • 製藥和生物技術公司
  • 學術和研究機構
  • 受託研究機構（CRO）

第五部分：按國家分類

  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 其他

市場趨勢、促進因素與挑戰

市場趨勢

  • CRISPR/Cas9 和基因編輯技術的應用日益廣泛。
  • 人們對個人化醫療和標靶治療的興趣日益濃厚
  • 擴展罕見疾病和複雜疾病的基因改造模型
  • 加強學術機構與生技公司之間的合作

市場促進因素

  • 藥物研發領域對先進臨床前模型的需求日益成長。
  • 加大對生技與生命科學領域的研發投入
  • 慢性病和遺傳性疾病盛行率增加
  • 強而有力的法規結構以支持生物醫學研究

市場挑戰

  • 關於動物實驗和基因改造的倫理問題
  • 基因改造模型開發成本高成本且複雜
  • 歐洲國家有嚴格的監管要求
  • 準確重現特定人類疾病狀態的局限性

本報告考察了歐洲基因改造動物模型市場，總結了關鍵趨勢、市場影響因素、法律制度、市場規模趨勢和預測、按各個細分市場和地區/主要國家進行的詳細分析、競爭格局以及主要企業的概況。

目錄

執行摘要

範圍和定義

第1章 市場：產業展望

  • 市場概覽
    • 市場概覽與生態系統
  • 市場趨勢
    • 影響分析
    • 對個人化醫療的需求日益成長
  • 監理情勢
    • 歐洲
  • 價格分析
    • 產生成本（創建新模型的成本）
    • 購置成本（購買現有型號的成本）
    • 其他額外費用
  • 技術展望
  • 市場動態
    • 促進因素、挑戰和機會：當前和未來影響評估
    • 市場促進因素
    • 市場限制因素
    • 市場機遇

第2章 區域

  • 區域概況
  • 歐洲
    • 區域概覽
    • 市場成長促進因素
    • 威脅市場的因素
    • 市場規模及預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 其他

第3章：競爭標竿分析與公司概況

  • 公司簡介
    • genOway
    • Sigma-Aldrich Co. (Merck Group)
    • Janvier Group (Janvier Labs)

第4章：調查方法

Product Code: BHL3663SS

This report can be delivered in 2 working days.

Market Overview

The Europe transgenic animal model market is experiencing steady growth, driven by increasing demand for advanced preclinical research tools, rising investments in biotechnology, and expanding applications in drug discovery and genetic research. Transgenic animal models play a critical role in understanding disease mechanisms and developing targeted therapeutics. The global transgenic animal model market is expected to witness significant growth during the forecast period 2025-2035, with Europe emerging as a key regional contributor due to strong research infrastructure and regulatory support. Countries such as Germany, the U.K., and France are at the forefront, fostering innovation in genetic engineering and biomedical research. The Europe transgenic animal model market is projected to reach $2,234.7 million by 2035 from $906.5 million in 2025, growing at a CAGR of 9.44% during the forecast period 2025-2035.

KEY MARKET STATISTICS
Forecast Period2025 - 2035
2025 Evaluation$906.5 Million
2035 Forecast$2,234.7 Million
CAGR9.44%

Market Introduction

The Europe transgenic animal model market represents a vital segment of the life sciences and biotechnology industry, focusing on genetically modified animals that carry foreign genes inserted into their genome. These models are widely used in biomedical research to study gene function, disease progression, and therapeutic responses. Transgenic animal models, particularly mice and rats, have become indispensable tools in preclinical research, enabling scientists to replicate human disease conditions with high accuracy.

In Europe, the demand for transgenic animal models is being driven by increasing research activities in genomics, oncology, neurology, and rare diseases. The region's strong academic and research ecosystem, supported by government funding and collaborations with pharmaceutical and biotechnology companies, is accelerating the adoption of advanced genetic engineering technologies such as CRISPR/Cas9 and gene editing platforms.

Moreover, the rising focus on personalized medicine and targeted therapies is further boosting the need for precise and reliable animal models. Regulatory frameworks in Europe ensure ethical use and standardization, promoting high-quality research practices. Additionally, the presence of leading research institutions and biotech firms is fostering innovation and commercialization of transgenic animal models.

As the demand for efficient drug development and disease modeling grows, the Europe transgenic animal model market is poised for significant expansion, supported by technological advancements and increasing R&D investments.

Market Segmentation:

Segmentation 1: By Technology

  • CRISPR/CAS-9
  • Microinjections
  • Embryonic Stem Cell Injections
  • Others

Segmentation 2: By Animal Type

  • Rodent (Mice & Rats)
  • Rabbits
  • Pigs
  • Others

Segmentation 3: By Application

  • Drug Discovery and Development
  • Disease Research
  • Gene Function Studies
  • Toxicology and Safety Testing
  • Others

Segmentation 4: By End User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations (CROs)

Segmentation 5: by Country

  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest-of-Europe

Market Trends, Drivers, and Challenges

Market Trends

  • Increasing adoption of CRISPR/Cas9 and gene-editing technologies
  • Growing focus on personalized medicine and targeted therapies
  • Expansion of transgenic models for rare and complex diseases
  • Rising collaborations between academic institutions and biotech firms

Market Drivers

  • Growing demand for advanced preclinical models in drug discovery
  • Increasing R&D investments in biotechnology and life sciences
  • Rising prevalence of chronic and genetic diseases
  • Strong regulatory frameworks supporting biomedical research

Market Challenges

  • Ethical concerns regarding animal testing and genetic modification
  • High cost and complexity of developing transgenic models
  • Stringent regulatory requirements across European countries
  • Limitations in replicating certain human disease conditions accurately

How This Report Can Add Value?

Product/Innovation Strategy: The report offers in-depth insights into the latest technological advancements in transgenic animal model, enabling organizations to drive innovation and develop cutting-edge products tailored to market needs.

Growth/Marketing Strategy: By providing comprehensive market analysis and identifying key growth opportunities, the report equips organizations with the knowledge to craft targeted marketing strategies and expand their market presence effectively.

Competitive Strategy: The report includes a thorough competitive landscape analysis, helping organizations understand their competitors' strengths and weaknesses and allowing them to strategize effectively to gain a competitive edge in the market.

Regulatory and Compliance Strategy: It provides updates on evolving regulatory frameworks, approvals, and industry guidelines, ensuring organizations stay compliant and accelerate market entry for new transgenic animal model products.

Investment and Business Expansion Strategy: By analyzing market trends, funding patterns, and partnership opportunities, the report assists organizations in making informed investment decisions and identifying potential M&A opportunities for business growth.

Key Market Players and Competition Synopsis

Profiled companies have been selected based on inputs gathered from primary experts, as well as analyzing company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • genOway
  • Sigma-Aldrich Co. (Merck Group)
  • Janvier Group

Table of Contents

Executive Summary

Scope and Definition

1 Market: Industry Outlook

  • 1.1 Market Overview
    • 1.1.1 Market Overview and Ecosystem
  • 1.2 Market Trends
    • 1.2.1 Impact Analysis
    • 1.2.2 Rising Demand for Personalized Medicine
  • 1.3 Regulatory Landscape
    • 1.3.1 Europe
      • 1.3.1.1 Germany
      • 1.3.1.2 U.K.
  • 1.4 Pricing Analysis
    • 1.4.1 Generation Costs (Creating New Models)
    • 1.4.2 Acquisition Costs (Purchasing Existing Models)
    • 1.4.3 Additional Costs
  • 1.5 Technology Landscape
  • 1.6 Market Dynamics
    • 1.6.1 Drivers, Challenges, and Opportunities: Current and Future Impact Assessment
    • 1.6.2 Market Drivers
      • 1.6.2.1 Growing Number of Pharmaceutical Research and Drug Development Activities
      • 1.6.2.2 Technological Advancements in Genetic Engineering
      • 1.6.2.3 Increasing Demand for Advanced Disease Models for Drug Discovery
    • 1.6.3 Market Restraints
      • 1.6.3.1 High Maintenance Cost of Animal Models
      • 1.6.3.2 Strict Regulations and Guidelines
    • 1.6.4 Market Opportunities
      • 1.6.4.1 Emergence of CRISPR as a Powerful Tool for Biomedical Research Field
      • 1.6.4.2 Increasing Demand for Disease-Specific Models

2 Region

  • 2.1 Regional Summary
  • 2.2 Europe
    • 2.2.1 Regional Overview
    • 2.2.2 Driving Factors for Market Growth
    • 2.2.3 Factors Challenging the Market
    • 2.2.4 Market Sizing and Forecast
      • 2.2.4.1 Europe Transgenic Animal Model Market, by Technology
      • 2.2.4.2 Europe Transgenic Animal Model Market, by Animal Type
      • 2.2.4.3 Europe Transgenic Animal Model Market, by Application
      • 2.2.4.4 Europe Transgenic Animal Model Market, by End User
      • 2.2.4.5 Europe Transgenic Animal Model Market, by Country
    • 2.2.5 U.K.
      • 2.2.5.1 Country Overview
      • 2.2.5.2 U.K. Transgenic Animal Model Market, by Technology
      • 2.2.5.3 U.K. Transgenic Animal Model Market, by Animal Type
      • 2.2.5.4 U.K. Transgenic Animal Model Market, by Application
      • 2.2.5.5 U.K. Transgenic Animal Model Market, by End User
    • 2.2.6 Germany
      • 2.2.6.1 Country Overview
      • 2.2.6.2 Germany Transgenic Animal Model Market, by Technology
      • 2.2.6.3 Germany Transgenic Animal Model Market, by Animal Type
      • 2.2.6.4 Germany Transgenic Animal Model Market, by Application
      • 2.2.6.5 Germany Transgenic Animal Model Market, by End User
    • 2.2.7 France
      • 2.2.7.1 Country Overview
      • 2.2.7.2 France Transgenic Animal Model Market, by Technology
      • 2.2.7.3 France Transgenic Animal Model Market, by Animal Type
      • 2.2.7.4 France Transgenic Animal Model Market, by Application
      • 2.2.7.5 France Transgenic Animal Model Market, by End User
    • 2.2.8 Italy
      • 2.2.8.1 Country Overview
      • 2.2.8.2 Italy Transgenic Animal Model Market, by Technology
      • 2.2.8.3 Italy Transgenic Animal Model Market, by Animal Type
      • 2.2.8.4 Italy Transgenic Animal Model Market, by Application
      • 2.2.8.5 Italy Transgenic Animal Model Market, by End User
    • 2.2.9 Spain
      • 2.2.9.1 Country Overview
      • 2.2.9.2 Spain Transgenic Animal Model Market, by Technology
      • 2.2.9.3 Spain Transgenic Animal Model Market, by Animal Type
      • 2.2.9.4 Spain Transgenic Animal Model Market, by Application
      • 2.2.9.5 Spain Transgenic Animal Model Market, by End User
    • 2.2.10 Rest-of-the- Europe
      • 2.2.10.1 Country Overview
      • 2.2.10.2 Rest of the Europe Transgenic Animal Model Market, by Technology
      • 2.2.10.3 Rest of the Europe Transgenic Animal Model Market, by Animal Type
      • 2.2.10.4 Rest of the Europe Transgenic Animal Model Market, by Application
      • 2.2.10.5 Rest of the Europe Transgenic Animal Model Market, by End User

3 Competitive Benchmarking and Company Profiles

  • 3.1 Company Profiles
    • 3.1.1 genOway
      • 3.1.1.1 Overview
    • 3.1.2 Sigma-Aldrich Co. (Merck Group)
      • 3.1.2.1 Overview
    • 3.1.3 Janvier Group (Janvier Labs)
      • 3.1.3.1 Overview

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Inclusion and Exclusion
    • 4.1.4 Data Triangulation
  • 4.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Europe Transgenic Animal Model Market (by Scenario), $Million, 2024, 2028, and 2035
  • Figure 2: Europe Transgenic Animal Model Market, 2024 and 2035
  • Figure 3: Europe Transgenic Animal Model Market Snapshot
  • Figure 4: Transgenic Animal Model Market, $Million, 2024 and 2035
  • Figure 5: Europe Transgenic Animal Model Market (by Technology), $Million, 2024, 2028, and 2035
  • Figure 6: Europe Transgenic Animal Model Market (by Animal Type), $Million, 2024, 2028, and 2035
  • Figure 7: Europe Transgenic Animal Model Market (by Application), $Million, 2024, 2028, and 2035
  • Figure 8: Europe Transgenic Animal Model Market (by End User), $Million, 2024, 2028, and 2035
  • Figure 9: Europe Transgenic Animal Model Market Segmentation
  • Figure 10: Key Stakeholders of Transgenic Animal Model Market
  • Figure 11: Transgenic Animals: Timeline of Key Events
  • Figure 12: Role of Humanized Mouse Models in Development of New Precision and Personalized Medicine Strategies
  • Figure 13: Regulatory Bodies of Transgenic Animals in Europe
  • Figure 14: Regulatory Bodies of Transgenic Animals in Germany
  • Figure 15: Regulatory Process
  • Figure 16: Evolution of Transgenic Technologies
  • Figure 17: Europe Drug Development Pipeline, 2019 and 2024
  • Figure 18: Major Technical Advances in Genome Editing and Delivery in Mice and Rats from 1980s to 2020s
  • Figure 19: Europe Transgenic Animal Model Market, $Million, 2024-2035
  • Figure 20: Inclusion and Exclusion Criteria for Europe Transgenic Animal Model Market
  • Figure 21: Data Triangulation
  • Figure 22: Top-Down and Bottom-Up Approach
  • Figure 23: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Cost of Generating New Transgenic Animals
  • Table 3: Cost of Purchasing Existing Models
  • Table 4: Additional Costs
  • Table 5: Transgenic Animal Model Market (by Region), $Million, 2024-2035
  • Table 6: Europe Transgenic Animal Model Market (by Technology), $Million, 2024-2035
  • Table 7: Europe Transgenic Animal Model Market (by Animal Type), $Million, 2024-2035
  • Table 8: Europe Transgenic Animal Model Market (by Application), $Million, 2024-2035
  • Table 9: Europe Transgenic Animal Model Market (by End User), $Million, 2024-2035
  • Table 10: Europe Transgenic Animal Model Market (by Country), $Million, 2024-2035
  • Table 11: U.K. Transgenic Animal Model Market (by Technology), $Million, 2024-2035
  • Table 12: U.K. Transgenic Animal Model Market (by Animal Type), $Million, 2024-2035
  • Table 13: U.K. Transgenic Animal Model Market (by Application), $Million, 2024-2035
  • Table 14: U.K. Transgenic Animal Model Market (by End User), $Million, 2024-2035
  • Table 15: Germany Transgenic Animal Model Market (by Technology), $Million, 2024-2035
  • Table 16: Germany Transgenic Animal Model Market (by Animal Type), $Million, 2024-2035
  • Table 17: Germany Transgenic Animal Model Market (by Application), $Million, 2024-2035
  • Table 18: Germany Transgenic Animal Model Market (by End User), $Million, 2024-2035
  • Table 19: France Transgenic Animal Model Market (by Technology), $Million, 2024-2035
  • Table 20: France Transgenic Animal Model Market (by Animal Type), $Million, 2024-2035
  • Table 21: France Transgenic Animal Model Market (by Application), $Million, 2024-2035
  • Table 22: France Transgenic Animal Model Market (by End User), $Million, 2024-2035
  • Table 23: Italy Transgenic Animal Model Market (by Technology), $Million, 2024-2035
  • Table 24: Italy Transgenic Animal Model Market (by Animal Type), $Million, 2024-2035
  • Table 25: Italy Transgenic Animal Model Market (by Application), $Million, 2024-2035
  • Table 26: Italy Transgenic Animal Model Market (by End User), $Million, 2024-2035
  • Table 27: Spain Transgenic Animal Model Market (by Technology), $Million, 2024-2035
  • Table 28: Spain Transgenic Animal Model Market (by Animal Type), $Million, 2024-2035
  • Table 29: Spain Transgenic Animal Model Market (by Application), $Million, 2024-2035
  • Table 30: Spain Transgenic Animal Model Market (by End User), $Million, 2024-2035
  • Table 31: Rest of the Europe Transgenic Animal Model Market (by Technology), $Million, 2024-2035
  • Table 32: Rest of the Europe Transgenic Animal Model Market (by Animal Type), $Million, 2024-2035
  • Table 33: Rest of the Europe Transgenic Animal Model Market (by Application), $Million, 2024-2035
  • Table 34: Rest of the Europe Transgenic Animal Model Market (by End User), $Million, 2024-2035